glp-1 tri New strategies for the treatment of obesity and metabolic dysfunctions Nutritional Support for Patients on
Description
Most effort has been directed towards development of anorexigenic drugs [9]
Do not stop semaglutide without discussing with your prescriber
Published 2021 Jul 26
Importantly, in terms of serious adverse events there was one in the placebo arm (cholecystitis) and two in liraglutide arm (left upper quadrant pain and abdominal pain)
